证券代码：920039 证券简称：国义招标 公告编号：2026-013 国义招标股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 289,245,589.51 | 326,549,415.63 | -11.42% | | 利润总额 | 38,050,054.75 | 67,043,541.60 | -43.25% | | 归属于上市公司股 | 32,814,212.84 | 55,638,247.76 | -41.02% | | 东的净利润 | | | | | 归属于上市公司股 | 31,403,543.47 | 50,941, ...

Financial Performance - Total revenue for 2025 is expected to be CNY 37.33 million, a decrease of 77.89% compared to the previous year[3] - The net profit attributable to shareholders of the parent company is projected to be CNY -316.84 million, worsening from CNY -240.20 million in the previous year[3] - The basic earnings per share for 2025 is projected at CNY -0.55, compared to CNY -0.42 in the previous year[3] - The company’s weighted average return on net assets is projected to be -18.91%[3] - The company expects to continue incurring losses in 2025 due to high R&D costs and insufficient revenue from technology licensing and cooperation[7] Assets and Equity - The total assets decreased by 11.29% to CNY 1,703.88 million from CNY 1,920.82 million at the beginning of the period[4] - The equity attributable to shareholders of the parent company fell by 15.17% to CNY 1,536.14 million[4] Research and Development - The company maintained a high level of R&D investment, with ongoing clinical trials for multiple core projects, including D-0502 and D-2570[5] - The company is advancing two innovative preclinical candidates, YF087 and YF550, which show promising anti-tumor potential[6] - The company emphasizes the importance of ongoing R&D and technology platform development for long-term growth[6]

Financial Performance - Total revenue for 2025 reached CNY 3,213,917.13 million, an increase of 17.96% compared to CNY 2,724,636.68 million in the previous year[5] - Net profit attributable to shareholders was CNY 88,916.84 million, reflecting a growth of 25.75% from CNY 70,711.57 million year-on-year[5] - Basic earnings per share increased by 24.11% to CNY 1.39 from CNY 1.12 in the previous year[5] - The net profit after deducting non-recurring gains and losses grew by 30.77%, driven by the factors mentioned in the operational performance analysis[7] Asset and Equity Growth - The company's total assets increased by 11.69% to CNY 2,393,174.38 million from CNY 2,142,608.26 million at the beginning of the period[7] - The equity attributable to shareholders rose by 24.32% to CNY 901,447.38 million, up from CNY 725,090.82 million[7] - The weighted average return on equity increased to 11.44%, up from 10.15% in the previous year[5] Operational Highlights - The lithium hexafluorophosphate business turned profitable starting November, benefiting from market price recovery and increased capacity utilization[6] - The company focused on optimizing product structure and expanding into emerging markets, contributing to improved profitability[6] - The company continues to enhance its global supply capabilities with ongoing production in Thailand and Mexico, supporting revenue growth[6]

Financial Performance - The company's operating revenue for the reporting period reached CNY 2,580,843,470.20, representing a year-on-year increase of 12.44%[4] - The total profit amounted to CNY 218,637,200.34, reflecting a growth of 9.70% compared to the previous year[4] - Net profit attributable to shareholders was CNY 173,726,056.32, up by 10.90% year-on-year[4] - The basic earnings per share increased to CNY 0.9422, marking a growth of 6.45%[4] Assets and Equity - Total assets at the end of the reporting period were CNY 2,251,240,810.41, a significant increase of 36.69% from the beginning of the period[4] - Shareholders' equity attributable to the company reached CNY 1,154,899,104.28, up 66.56% from the start of the period[4] Investment and Growth Strategy - The company increased its R&D investment, enhancing product competitiveness, particularly in the mining tire segment[7] - Domestic and overseas sales revenue experienced double-digit growth due to increased mining investment and demand driven by global energy transition[7] - The company completed a public offering of shares and was listed on the Beijing Stock Exchange, which contributed to the increase in total assets and equity[8] - The company emphasizes a strategy focused on "stable growth, high quality, capability building, and risk control" to drive high-quality development[7]

证券代码：920682 证券简称：球冠电缆 公告编号：2026-002 宁波球冠电缆股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 单位：元 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 3,790,545,951.62 | 3,584,725,310.92 | 5.74% | | 利润总额 | 108,342,003.70 | 144,780,903.45 | -25.17% | | 归属于上市公司股东 | 95,187,874.85 | 132,916,429.19 | -28.39% | | 的净利润 | | | | | 归属于上市公司股东 | 92,378,192 ...

洛阳科创新材料股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 证券代码：920580 证券简称：科创新材 公告编号：2026-012 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 单位：元 1.原材料成本下降，毛利率提升：报告期内，公司功能耐火材料产品的主 要原材料价格下降，显著降低产品成本，推动毛利率上升。同时，经营性现金 流改善带动银行贷款规模减少，财务费用相应下降。 2.募投项目产能释放，盈利结构优化：随着募投项目产品——碳化硅复合 材料的产能逐步释放，固定成本得到有效摊薄，毛利率稳步提升。此外，产品 市场渗透加速，收入实现显著增长，为公司盈利水平的显著提升提供了有力支 撑。 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营 ...

证券代码：920519 证券简称：万德股份 公告编号：2026-007 西安万德能源化学股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 单位：元 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 441,756,332.57 | 526,622,829.96 | -16.12% | | 利润总额 | 25,772,571.93 | 37,542,198.23 | -31.35% | | 归属于上市公司股 | 21,604,352.47 | 30,634,639.03 | -29.48% | | 东的净利润 | | | | | 归属于上市公司股 | 19,052,685.81 ...

Financial Performance - The company's operating revenue for the reporting period is CNY 552,381,969.42, a decrease of 12.87% compared to the same period last year[3] - The total profit for the period is CNY 23,136,016.12, down 56.73% year-on-year[3] - Net profit attributable to shareholders is CNY 19,673,113.63, reflecting a decline of 58.99% compared to the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses is CNY 18,362,565.98, a decrease of 60.85% year-on-year[3] - Basic earnings per share are CNY 0.24, down 68.83% from the same period last year[3] Assets and Equity - Total assets at the end of the reporting period amount to CNY 835,332,033.01, a decrease of 4.12% year-on-year[5] - Shareholders' equity attributable to the company is CNY 516,240,129.52, down 1.58% compared to the beginning of the period[5] Operational Challenges - The company's gross margin has been impacted by rising raw material costs, particularly for metals like copper, aluminum, and tin[5] - The decline in revenue is attributed to decreased sales in the home appliance sector and a strategic reduction in low-margin orders in the new energy sector[5] Cautionary Notes - The financial data presented is preliminary and has not been audited, cautioning investors about potential risks[6]

证券代码：920392 证券简称：佳合科技 公告编号：2026-002 二、经营业绩和财务状况情况说明 （一）报告期的经营情况、财务状况及影响经营业绩的主要因素 报告期内，公司预计实现营业收入 738,009,005.99 元，较上年同期增长 13.74%；归属于上市公司股东的净利润为 20,582,398.70 元，较上年同期下降 39.17%；归属于上市公司股东的扣除非经常性损益的净利润为 19,954,073.09 元， 较上年同期增长 2.00%；基本每股收益为 0.27 元，较上年同期下降 53.45%。 报告期末，预计公司总资产为 744,140,268.60 元，较期初增长 9.86%；归属 于上市公司股东的所有者权益为 341,020,810.20 元，较期初增长 2.68%；归属于 上市公司股东的每股净资产为 4.48 元，较期初下降 20.85%。 昆山佳合纸制品科技股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 20 ...

证券代码：920422 证券简称：润普食品 公告编号：2026-008 江苏润普食品科技股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 单位：元 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 494,721,092.55 | 517,085,276.92 | -4.33% | | 利润总额 | 22,644,771.96 | 16,808,660.39 | 34.72% | | 归属于上市公司 | 18,684,848.32 | 14,958,737.19 | 24.91% | | 股东的净利润 | | | | | 归属于上市公司 | 15,804,964.59 | 11 ...